
    
      This is a randomized double-blinded study investigating the role of DigiFab in patients with
      elevated risk of acute kidney injury undergoing CABG surgery. University of Maryland Medical
      Center (UMMC) and University of Maryland St Joseph Medical Center (UMSJMC) patients who are
      undergoing CABG, meet the inclusion criteria and provide consent will be enrolled in this
      study and randomized to either DigiFab arm or the placebo (vehicle) arm. The study involves a
      follow up period of 72 hours post CABG surgery.
    
  